At a glance
The March 21, 2022, Clinical Laboratory COVID-19 Response (CLCR) call included antigen testing guidance update, HHS reporting requirements update, and SARS-CoV-2 testing using rapid antigen tests key findings, as well as updates from FDA.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
Antigen Testing Guidance Update: Reynolds (Ren) Salerno, CDC Division of Laboratory Systems (DLS)
HHS Reporting Requirements Update: Jason Hall, CDC Data, Analytics, and Visualization Task Force
Key Findings for SARS-CoV-2 Testing Using Rapid Antigen Tests from RADx Clinical Studies Core: Apurv Soni, University of Massachusetts Chan Medical School
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.